[1]
S. Razmjoo, S. M. Hosseini, A. Bagheri, M. Feli, and F. Karimi, “Real-World Clinical Outcomes of Low Dose versus Standard Dose Abiraterone in Patients with Metastatic Castration-Resistant Prostate Cancer: A Prospective Pragmatic Study”, apjcb, vol. 9, no. 4, pp. 447-454, Oct. 2024.